Submitted by paige-dawkins on Mon, 30/04/2018 - 15:54
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Submitted by Nicola-Swanborough on Tue, 24/04/2018 - 11:44
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.
Submitted by Nicola-Swanborough on Fri, 23/03/2018 - 14:10
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'
Submitted by Nicola-Swanborough on Thu, 15/03/2018 - 13:19
The Charity Tax Commission has launched a consultation seeking views on whether and how the tax treatment of charities - estimated to be worth around £3.7bn a year - needs to be reformed.
Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Submitted by Nicola-Swanborough on Tue, 09/01/2018 - 10:55
Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.
Submitted by Nicola-Swanborough on Mon, 08/01/2018 - 16:09
Epilepsy Society's chief executive Clare Pelham looks back over the year, at the highs and - sadly - a very snowy low.
Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 19:10
Although we could not see them as we watched today's sodium valproate debate via Parliament Live TV, the presence of three women -Janet Williams, Emma Murphy and Deborah Mann - as they sat in the public gallery, was very much felt in the House of Commons.
Submitted by Nicola-Swanborough on Thu, 19/10/2017 - 11:45
Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.